GIANT BIOGENE

2367
20.1402.34% ( +0.460 )
Delay Closed: Nov 16, 16:08:11

Financials

H1 2026 Earnings

Financial report interval: 2025.12.30 - 2026.06.30

Overview: GIANT BIOGENE(02367) the Revenue is 3.37 B (-1.19%), Beat estimate;the EBIT is 1.254 B (-15.88%), Beat estimate.

Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
3.37B1.19%
3.34B1.95%
+0.03B0.76%
EBITExceed expectations
1.25B15.88%
1.15B22.87%
+0.10B6.99%

Upcoming earnings report - FY2026 Q3 Earning Release

Available dateNov 19, 2026
Estimate Revenue--
Estimate EBIT--
Estimate EPS--

Revenue

ActualEstimateUnit: HKD
Quarterly

EBIT

ActualEstimateUnit: HKD
Quarterly

Net income

ActualEstimateUnit: HKD
Quarterly

EPS

ActualEstimateUnit: HKD
Quarterly